BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34931386)

  • 21. Impact of positive margins on outcomes of oropharyngeal squamous cell carcinoma according to p16 status.
    Molony P; Kharytaniuk N; Boyle S; Woods RSR; O'Leary G; Werner R; Heffron C; Feeley L; Sheahan P
    Head Neck; 2017 Aug; 39(8):1680-1688. PubMed ID: 28560813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant Radiotherapy in Surgically Treated HPV-Positive Oropharyngeal Carcinoma with Adverse Pathological Features.
    Soliman SI; Faraji F; Pang J; Mell LK; Califano JA; Orosco RK
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer.
    Giacalone NJ; Qureshi MM; Mak KS; Kirke D; Patel SA; Shah BA; Salama AR; Jalisi S; Truong MT
    Laryngoscope; 2018 Apr; 128(4):831-840. PubMed ID: 28833217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
    Lee J; Chang JS; Kwon HJ; Kim SH; Shin SJ; Keum KC
    Jpn J Clin Oncol; 2016 Oct; 46(10):911-918. PubMed ID: 27474125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
    Zenga J; Wilson M; Adkins DR; Gay HA; Haughey BH; Kallogjeri D; Michel LS; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1118-27. PubMed ID: 25902372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
    Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
    JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for extranodal extension in HPV-associated oropharyngeal carcinoma: evaluation of a CT-based deep learning algorithm in patient data from a multicentre, randomised de-escalation trial.
    Kann BH; Likitlersuang J; Bontempi D; Ye Z; Aneja S; Bakst R; Kelly HR; Juliano AF; Payabvash S; Guenette JP; Uppaluri R; Margalit DN; Schoenfeld JD; Tishler RB; Haddad R; Aerts HJWL; Garcia JJ; Flamand Y; Subramaniam RM; Burtness BA; Ferris RL
    Lancet Digit Health; 2023 Jun; 5(6):e360-e369. PubMed ID: 37087370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of microscopic versus macroscopic extranodal extension in oral cavity squamous cell carcinoma: National cancer database analysis and review of the literature.
    Quinton BA; Cabrera CI; Tamaki A; Li S; Fowler N; Rezaee R; Lavertu P; Teknos T; Pan Q; Thuener J
    Am J Otolaryngol; 2022; 43(4):103511. PubMed ID: 35609426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of care and survival impact of adjuvant chemoradiotherapy for oropharyngeal cancer with intermediate-risk features.
    Goel AN; Sangar S; Mukdad L; Heaton CM; Ryan WR; Wang MB; Long JL; St John MA
    Head Neck; 2019 Sep; 41(9):3177-3186. PubMed ID: 31107584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
    Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
    Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computed tomography performance in predicting extranodal extension in HPV-positive oropharynx cancer.
    Faraji F; Aygun N; Coquia SF; Gourin CG; Tan M; Rooper LM; Eisele DW; Fakhry C
    Laryngoscope; 2020 Jun; 130(6):1479-1486. PubMed ID: 31411751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of contralateral lymph nodal involvement and extranodal extension on survival of surgically managed HPV-positive oropharyngeal cancer staged with the AJCC eighth edition.
    Miccio JA; Verma V; Kelly J; Kann BH; An Y; Park HS; Eskander A; Burtness B; Husain Z
    Oral Oncol; 2019 Dec; 99():104447. PubMed ID: 31630059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma.
    Ho AS; Luu M; Kim S; Tighiouart M; Mita AC; Scher KS; Mallen-St Clair J; Walgama ES; Lin DC; Nguyen AT; Zumsteg ZS
    Cancer; 2021 May; 127(10):1590-1597. PubMed ID: 33595897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes following observation, post-operative radiation therapy, or post-operative chemoradiation for HPV-associated oropharyngeal squamous cell carcinomas.
    Singh R; Song S
    Oral Oncol; 2023 Nov; 146():106493. PubMed ID: 37713768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the National Cancer Data Base.
    Zhan KY; Eskander A; Kang SY; Old MO; Ozer E; Agrawal AA; Carrau RL; Rocco JW; Teknos TN
    Oral Oncol; 2017 Oct; 73():152-159. PubMed ID: 28939068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Extracapsular Spread With Survival According to Human Papillomavirus Status in Oropharynx Squamous Cell Carcinoma and Carcinoma of Unknown Primary Site.
    Kharytaniuk N; Molony P; Boyle S; O'Leary G; Werner R; Heffron C; Feeley L; Sheahan P
    JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):683-690. PubMed ID: 27196434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
    Lee B; Choi YJ; Kim SO; Lee YS; Hong JY; Baek JH; Lee JH
    Korean J Radiol; 2019 Aug; 20(8):1266-1274. PubMed ID: 31339014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.